Story preview

Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water

About this story

Published
Oct 1, 2026, 3:00 PM UTC

Continue reading on the publisher site for the full article.

Read on publisher →24/7 Wall St.

News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee

At a glance

Coverage

Tone

Who else is covering this

Where in the world it’s covered

Coverage over time

Tone of the coverage

About the publisher

Related topics

Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water · News Atlas